The Global Market for Anti-Adhesion Products is Projected to Reach US$1.4 Billion by 2024

Increasing Awareness & Efforts to Reduce Post-Surgical Complications to Drive Growth in the Global Anti-Adhesion Products Market, According to a New Report by Global Industry Analysts, Inc.

                                                                                                

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size, and demand forecasts on the global Anti-Adhesion Products market. The global market for Anti-Adhesion Products is projected to reach US$1.4 billion by 2024, driven by increasing awareness over the availability of innovative anti-Adhesion Products, as well as the efforts to reduce post-surgical complications arising out of adhesion. 

                                                                                        

In the healthcare sector, the term ‘adhesion’ denotes sticky fibrous band of scar tissue typically formed between organs and tissues when they adhere to each other following a surgery or any non-surgical trauma. While adhesions may occur due to non-surgical trauma such as blunt force, infection, endometriosis, chemotherapy, radiation or cancer, they are however most commonly caused due to surgery. Over 85% of adhesion cases are a result of post-surgical complications, with more than 50% of all patients affected by adhesion following a surgery. Adhesion formation has and continues to remain the most common post-surgical complication with huge unmet market needs. Adhesion formation after a surgery is a part of natural healing response to tissue trauma and a normal step in a body’s post-surgery healing process. However, when they connect wrong or unrelated tissues with each other, adhesions can lead to serious clinical implications such as intestinal blockage, pelvic pain, sensation loss and infertility depending on their size and location. 

The ever-present risk of adhesions associated with surgical procedures is generating demand for efficient solutions to tackle the problem. Research studies have revealed that numerous undesirable complications can be avoided if the development of adhesion is successfully prevented within 3-5 days post-surgery when tissue healing and regrowth begins. Demand is therefore especially high for advanced adhesion barriers capable of fully preventing the formation of adhesions. The growth in the market is led by factors such as demographic trends, number of surgical procedures, and growing awareness among patients and physicians alike on the medical implications of adhesions.

With over 250 million surgical procedures being performed annually across the globe, the number of patients exposed to the risk of post-surgical adhesion formation is extremely high, thereby creating significant demand for anti-adhesion products. Given that abdominal, gynaecological/pelvic and cardio-thoracic surgical procedures are followed by post-surgical adhesion formation, the market stands to benefit from the growing incidence of cardiovascular diseases and increase in reconstructive pelvic surgery among the aging women population. On the flip side, advent of minimally invasive surgeries, and novel surgical therapies, as well as lack of awareness among medical fraternity and patients, limited clinical efficacy data are some of the key restraints for market growth. 

As stated by the new market research report on Anti-Adhesion Products, the United States represents the largest market worldwide, followed by Europe. Asia-Pacific, on the other hand, ranks as the fastest growing market with a CAGR of 12% over the analysis period. Increasing incomes, coupled with better medical infrastructure, as well as growing awareness of post-surgical complications is driving the market in the region. In addition, medical tourism is also driving the growth of Anti-Adhesion Products in the region, as patients from developed countries demand world class facilities and procedures. General/Abdominal Surgery represents the largest application area for Anti-Adhesion products, followed by Gynecological Surgery applications. By form Anti-Adhesion Films represent the largest segment, while Anti-Adhesion Liquid formulations represent the fastest growing segment. Anti-Adhesion Gels are also expected to register above average growth over the analysis period.

Major players in the market include Anika Therapeutics, Inc., Baxter International Inc., Ethicon Inc., FzioMed, Inc., Integra LifeSciences Holdings Corporation, Magen OrthoMed Ltd., MAST Biosurgery AG, and Sanofi SA among others.

The research report titled "Anti-Adhesion Products: A Global Strategic Business Report" announced by Global Industry Analysts Inc., analyzes a wealth of data including technological trends, growth drivers and major challenges that are shaping the global Anti-Adhesion Products market, as well as profiles of leading vendors, mergers, acquisitions and other strategic industry activities. The report provides market estimates and projections in US$ for major geographic markets including the United States, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, and Rest of Asia-Pacific), Latin America and Rest of World. By application the market is analyzed by General/Abdominal Surgery, Gynecological Surgery, and Other Surgeries. In addition the global market is analyzed by Film, Gel, Liquid forms.

For enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.

To connect with us, visit our LinkedIn page.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.